MARIKA WALKER: Open Payments
NPI 1437469970 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 66 payments from 18 companies in 2025. Trend: 2023 $439 · 2024 $1,068 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $244 |
| Janssen Biotech, Inc. | 16 | $236 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $223 |
| GENZYME CORPORATION | 4 | $77 |
| Aimmune Therapeutics, Inc. | 3 | $72 |
| Madrigal Pharmaceuticals | 3 | $61 |
| Gilead Sciences, Inc. | 2 | $61 |
| Lilly USA, LLC | 3 | $54 |
| Ipsen Biopharmaceuticals, Inc | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
Products named: TREMFYA, ENTYVIO, RINVOQ, DUPIXENT, LINZESS, ZENPEP, REZDIFFRA, OMVOH.
Industry payments across FL — which companies pay providers there.
